Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M L, Amoedo"'
Autor:
M. L. Amoedo, Blai Coll, Maria Vittoria Arcidiacono, Angels Betriu, Montserrat Martínez-Alonso, Mercè Borràs, Elvira Fernández, Jose M. Valdivielso
Publikováno v:
Clinical Journal of the American Society of Nephrology. 6:303-310
Summary Background and objectives Vascular calcification (VC) has a significant effect in cardiovascular diseases on dialysis patients. However, VC is assessed with x-ray-based techniques, which do not inform about calcium localization (intima, media
Autor:
Mercè Borràs, Elvira Fernández, Joan Fibla, Jaume Almirall, M. L. Amoedo, Isabel Martínez, R. Saracho, Maria Paz Marco
Publikováno v:
Kidney International. 56(4):1349-1353
Vitamin D receptor genotype influences PTH and calcitriol levels in predialysis patients. Background BsmI vitamin D receptor (VDR) gene polymorphism has been associated with the severity of hyperparathyroidism in patients on hemodialysis. The aim of
Autor:
M. L. Amoedo, J. M. Piulats, M. J. Panadés, Muray S, Marco Mp, M. D. Boquet, J. Ramos, E. Fernandez
Publikováno v:
Postgraduate Medical Journal. 74:756-759
Accepted 23 April 1998 A 69-year-old woman was referred to our out-patient clinic because of long-term hypertension and stable chronic renal failure (creatinine 132 ,umol/l), which had been attributed to nephroangiosclerosis. She presented with a one
Autor:
Marco Mp, Mireia Junyent, Jose M. Valdivielso, Elvira Fernández, Mercè Borràs, Lourdes Craver, Montserrat Martínez-Alonso, M. L. Amoedo, Blai Coll, Felipe Sarró, Angels Betriu
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 25(9)
Background. Cardiovascular risk scoring (Score) does not specifically address chronic kidney disease (CKD) patients. The aim of our study is to quantify atherosclerosis using carotid ultrasound and ankle–brachial index (ABI) and to assess its addit
Publikováno v:
Nephrology Dialysis Transplantation. 13:3277-3279
Autor:
M L, Amoedo, M L, Martín, S, Muray, L, Craver, M J, Panadés, J, Ramos, L, Pérez Ruiz, E, Fernández
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 26(2)
Hypokalemia is generally associated to neuromuscular symtoms, acid-base disorders and even to rhabdomyolysis. However, chronic hypokalemia can induce chronic renal failure through a characteristic tubulointerstitial damage consisting on vacuolization
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 26(2)
Calcitriol has traditionally been the most widely used treatment for secondary hyperparathyroidism (SHPT) in uremic patients. There are currently no crossover equivalence studies of alphacalcidol versus calcitriol establishing which of the two deriva
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 24(5)
There has been increasing interest to find instruments to assess the HRQL quickly and easily in daily clinical practice. The main objective of this study is to measure the HRQL inhemodialysis patients using the Coop-Wonca Charts and to analyse whethe
Autor:
J L, Górriz, A, Sancho, L M, Pallardó, M L, Amoedo, M, Martín, P, Sanz, G, Barril, R, Selgas, M, Salgueira, A, Palma, M, de la Torre, I, Ferreras
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 22(1)
The aim of our study was to analyse patient characteristics, mortality and costs, all of them in relation to whether starting dialysis was planned or unplanned.A total of 362 patients (227 male and 135 female) from five hospitals of the National Heal
Autor:
Elvira Fernández, Lourdes Craver, Angel Rodriguez Jornet, Anna Oliveras, Marisa Martín, Xavier Montanyà, Xavier Gómez, Carme García, Laura García, Maria Isabel Real, Muray S, Manuel Vera, M. L. Amoedo, Albert Botey
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 39(1)
Percutaneous transluminal renal angioplasty (PTRA) has a beneficial effect on renal function in some, but not all, patients with atheromatous renal artery stenosis. Our aim is to identify factors influencing clinical success after PTRA in this group